(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

SMART CELLS FOR LIFE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

SMART CELLS FOR LIFE

ST13

US500000079311713

Classe

1, 5, 10, 42, 44

Pedido

79311713

Registro

6784096

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

31

Atualização mais recente

31/12/2023

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 10, 42, 44

Data de depósito

04/02/2021

Data de registro

12/07/2022

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

12/07/2022

Última transação

12/07/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

33

Localização do titular

CH

Examinador

AGREDA, SAMANTHA

Unidade examinadora

N50

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Tigen Pharma SA

Representantes

Stacey Halpern Knobbe, Martens, Olson & Bear, LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicalbiochemicalbiological and biotechnological preparationspolypeptides and proteinsfor use in industry and science; chemicalbiochemicalbiological and biotechnological preparationspolypeptides and proteinsfor use in the development being the manufacturemanufacture of reagents for industrial or scientific use; chemicalbiochemicalbiological and biotechnological preparationspolypeptides or proteinsfor use of laboratoriesdiagnostics and analyses for industrial or scientific use; chemicalbiochemicalbiological and biotechnological substancespolypeptides and proteinsfor use in the manufacture of pharmaceuticals; none of the foregoing being silicon and semiconductor materials or chemical compounds in the nature of Gallium arsenideIndium phosphideIndium gallium arsenideIndium gallium arsenide phosphidefor the production of enzyme substrates in the field of microelectronics and none of the foregoing being dietary and nutritional supplement or skin care products

Classe 5

Pharmaceutical products and medical preparationsgene-modified and non-gene-modified cellular therapies for the treatment of localized and systemic malignant hematological and oncological diseasesgenetic diseasesautoimmune diseases and infectious diseases; none of the foregoing being dietary and nutritional supplement or skin care products

Classe 10

Medical instrumentsequipment and apparatusinstrumentsequipment and apparatus for cell and cell material collectionthawingwashingselectionexpansionmodificationharvestingfinal formulationfreezingstorage and infusion into a patient in the fields of genetic diseasesautoimmune diseasesinfectious diseaseslocalized and systemic malignant hematological and oncological diseases and other cell and cell-material based diseases and conditions; none of the foregoing being dietary and nutritional supplement or skin care products

Classe 42

Scientific researchtechnological development of new products for third parties; medical research; scientific and industrial research in biotechnologybiologydiseasesgenetic diseasesautoimmune diseasesinfectious and tumor diseases and the treatment of diseasesgenetic diseasesautoimmune diseasesinfectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific servicesdevelopment of medicinesactive substances and vaccines; design and development of computer hardware and software for use in medical and scientific research and in the development of new productsin research and development of new products in the field of biotechnologybiologydiseasesgenetic diseasesautoimmune diseasesinfectious diseases and tumor diseases and the treatment of diseasesgenetic diseasesautoimmune diseasesinfectious diseases and tumor diseases; upgradingmaintenance and rental of computer software; updatingmaintenance and rental of computer software for use in medical and scientific research and in the development of new productsin research and development of new products in the field of biotechnologybiologydiseasesgenetic diseasesautoimmune diseasesinfectious diseases and tumor diseases and the treatment of diseasesgenetic diseasesautoimmune diseasesinfectious diseases and tumor diseases; software as a service (SaaS) services featuring software for controlling end-to-end process developmentmanufacturingqualitysupply chain steps and featuring artificial intelligence search engine software to be used in medical and scientific research and in the development of new products in research and development of new products in the field of biotechnologybiologydiseasesgenetic diseasesautoimmune diseasesinfectious diseases and tumor diseases and the treatment of diseasesgenetic diseasesautoimmune diseasesinfectious diseases and tumor diseases; chemical and biological laboratory services; none of the foregoing being dietary and nutritional supplement or skin care products

Classe 44

Medical services; pharmacy advice servicespharmaceutical consultation; medical clinic services provided by medical laboratories for diagnostic purposes; preparation and dispensing of medication; preparation of prescriptions by pharmacists; none of the foregoing being dietary and nutritional supplement or skin care products

Publicações

Histórico de despachos e eventos da marca no USPTO.

31 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

31/12/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

14/11/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

21/10/2022

FIMP

FINAL DISPOSITION PROCESSED

21/10/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/10/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/07/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/07/2022

GPNX

NOTIFICATION PROCESSED BY IB

03/05/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

26/04/2022

PUBO

PUBLISHED FOR OPPOSITION

26/04/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

13/04/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

13/04/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/04/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

24/03/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

24/03/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

24/03/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

24/03/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

24/03/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

15/02/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

14/02/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

14/02/2022

RFNT

REFUSAL PROCESSED BY IB

04/10/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

14/09/2021

RFRR

REFUSAL PROCESSED BY MPU

14/09/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

14/09/2021

CNRT

NON-FINAL ACTION WRITTEN

13/09/2021

DOCK

ASSIGNED TO EXAMINER

27/08/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

27/08/2021

MAFR

APPLICATION FILING RECEIPT MAILED

05/06/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/06/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

27/05/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace SMART CELLS FOR LIFE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.